| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 09/19/2006 | US7109231 Antiinflammatory agents; sepsis |
| 09/19/2006 | US7109230 Resistance-repellent retroviral protease inhibitors |
| 09/19/2006 | US7109224 Acyl guanidine compounds and use thereof |
| 09/19/2006 | US7109201 5-HT1D receptor antagonist activity; antidepressants |
| 09/19/2006 | US7109194 3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use |
| 09/19/2006 | US7108948 Organophotoreceptor with charge transport compositions |
| 09/19/2006 | US7108846 Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection |
| 09/14/2006 | WO2006096810A2 Methods and compositions for production, formulation and use of 1-aryl-3-azabicyclo[3.1.0] hexanes |
| 09/14/2006 | WO2006096802A1 Amorphous tegaserod maleate |
| 09/14/2006 | WO2006095568A1 Process for oxidation of organic compounds |
| 09/14/2006 | WO2006095183A1 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 09/14/2006 | WO2006094842A1 Acylated piperidihes as glycine transporter inhibitors |
| 09/14/2006 | WO2006070325A3 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists |
| 09/14/2006 | WO2006060535A3 Indole derivatives for use as ppar active compounds |
| 09/14/2006 | WO2006047452A3 Reactive 1,3’-crosslinked carbocyanines and their bioconjugates |
| 09/14/2006 | WO2006034337A3 Carbazole and cyclopentaindole derivatives to treat infection with hepatitis c virus |
| 09/14/2006 | WO2004073634A3 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/14/2006 | US20060205954 Process for the hydrogenation of aromatic compounds |
| 09/14/2006 | US20060205785 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/14/2006 | US20060205772 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type I |
| 09/14/2006 | US20060205751 Novel compounds |
| 09/14/2006 | US20060205744 Fused heterocyclic derivatives as ppar modulators |
| 09/14/2006 | US20060205726 e.g. 2-(2-{3-acetoxy-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetoxymethyl)-2-phenylmalonic acid diethyl ester; microsomal triglyceride transfer protein inhibitor in small intestine; antihyperlipidemic, antidiabetic agent; arteriosclerosis, coronary artery diseases, obesity |
| 09/14/2006 | CA2640120A1 Methods and compositions for production, formulation and use of 1-aryl-3-azabicyclo(3.1.0) hexanes |
| 09/14/2006 | CA2601980A1 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 09/14/2006 | CA2597120A1 Methods for oxidizing organic compounds |
| 09/13/2006 | EP1699803A1 Novel compounds |
| 09/13/2006 | EP1699791A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 09/13/2006 | EP1699768A2 Multifunctional amine capture agents |
| 09/13/2006 | EP1699762A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension |
| 09/13/2006 | EP1699761A1 Cb1 modulator compounds |
| 09/13/2006 | EP1497274B1 Terphenyl derivatives, preparation thereof, compositions containing same |
| 09/13/2006 | EP1412364B1 Platelet adp receptor inhibitors |
| 09/13/2006 | EP1406869B1 Taxol enhancer compounds |
| 09/13/2006 | EP1244621B1 Nitrile derivatives as cathepsin k inhibitors |
| 09/13/2006 | EP1082319B1 Benzocarbazole and indenoindole derived estrogenic agents |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1832921A Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 09/13/2006 | CN1832744A Treatment for alzheimer's disease and related conditions |
| 09/13/2006 | CN1832740A Indol-5 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 09/13/2006 | CN1832739A Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 09/13/2006 | CN1832738A Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 09/13/2006 | CN1830961A Process for preparing medicine for treating glycuresis, application of its pharmaceutical prepn. |
| 09/13/2006 | CN1830960A 10-phenyl hydroisoindolone type compounds, prepn. method and use thereof |
| 09/13/2006 | CN1830941A Compound having hydroxycarbonyl-halogenoalkyl side chain |
| 09/13/2006 | CN1274692C Total synthesizing meethod for pyrrole heterocyclic alkaloid aldisin |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/12/2006 | US7105567 Such as N-benzyl-N'-(2,6-dimethylphenyl)-N-(4-octylphenyl)urea for treating autoimmune diseases, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergies/asthma, atherosclerosis, and brain disorders |
| 09/12/2006 | US7105564 7-(3-{[5-(Pyrrole-1-sulfonyl)-thiophene-2-carbonyl]-amino}-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid; thromboxane A2 receptor and a prostaglandin D2 receptor; for all of eosinophilic infiltration, advance of respiratory anaphylaxis and respiratory contraction |
| 09/12/2006 | US7105563 5-ureido-3-[(4-(3-methoxyphenyl)pyrrol-2-yl)methylene]indolin-2-one and derivatives; inhibition of phosphoinositide-dependent kinase-1 (PDK-1). |
| 09/12/2006 | US7105562 2-methyl-6-[2-oxo-1,2-dihydro-indol-(3Z)-ylidene]1,4,5,6-tetrahydro-cyclopenta[b]pyrrole-3-carboxylic acid ethyl ester; disorders related to abnormal PK activity; |
| 09/12/2006 | US7105543 4-, 5-, 6- and 7-indole derivatives useful for the treatment of CNS disorders |
| 09/12/2006 | US7105539 such as N-[1-Carboxy-2-(1H-indol-3-yl)-ethyl]-3-(2-mercapto-acetylamino)-succinamic acid; endopeptidase (Phex/pex) inhibitors; for promoting generation of bone mass and treating or preventing diseases or conditions associated with phosphate metabolism defect; drug screening |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105516 Compounds for the treatment of premature ejaculation |
| 09/12/2006 | US7105515 Such as N-[3-(2-diethylaminoethyl)-1H-indol-5-yl]-5-chloro-3-methylbenzo[b]thiophene-2-sulphonamide for treating anxiety, depression, cognitive memory disorders and senile dementia, psychosis, infant hyperkinesia (ADHD, attention deficit/hyperactivity disorder) |
| 09/12/2006 | US7105514 2-methyl-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic; acidinhibit aldose reductase; treating diabetes mellitus, including, diabetic cataracts, retinopathy, nephropathy, and neuropathy |
| 09/12/2006 | US7105471 Arylphenyl-substituted cyclic ketoenols |
| 09/12/2006 | US7105258 Charge transport monomer, charge transport material, and process for producing the same |
| 09/12/2006 | CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 09/08/2006 | WO2006092710A1 Metabolites of 2-{3-[4-(2-isopropoxyphenyl) piperazin-1-yl]-propyl}-3a,4,7,7a-tetrahydro-1h-isoindole-1,3-(2h)-dione |
| 09/08/2006 | WO2006077024A3 5-aminoindole derivatives |
| 09/08/2006 | WO2006061759A3 9 , 9 ' - and 2 , 2 ' -substituted 3 , 3 ' -bicarbazolyl derivatives for use in semiconducting materials as a host matrix for phosphorescent emitters |
| 09/08/2006 | WO2006059347A3 Improved process for preparation of ramipril |
| 09/07/2006 | US20060199966 Indol-2-amides as glycogen phosphorylase inhibitors |
| 09/07/2006 | US20060199835 Neuroprotective and anti-proliferative compounds |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/07/2006 | US20060199799 Benzimidazolidinone derivatives as muscarinic agents |
| 09/07/2006 | US20060199223 Chemiluminescent compounds and their use |
| 09/06/2006 | EP1698618A1 Benzamide derivative |
| 09/06/2006 | EP1698611A1 Process for producing phenylacetic acid derivative |
| 09/06/2006 | EP1698338A2 S-methyl-dihydro-ziprasidone for the treatment of schizophrenia |
| 09/06/2006 | EP1698334A1 Pharmaceutically active isoindoline derivatives |
| 09/06/2006 | EP1697337A2 Ornithine derivatives as prostaglandin-e2-agonists or antagonists |
| 09/06/2006 | EP1697322A1 Substituted tetrahydrocarbazole and cyclopentanoindole derivatives |
| 09/06/2006 | EP1697321A1 2-halogen-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives |
| 09/06/2006 | EP1697320A1 A synthetic methodology for the reductive alkylation at the c-3 position of indoles |
| 09/06/2006 | EP1697304A1 Peroxisome proliferator activated receptor modulators |
| 09/06/2006 | EP1696915A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 09/06/2006 | CN1829775A Cyanine compounds, optical recording materials and optical recording media |
| 09/06/2006 | CN1829749A Vinyl monomer and polymer derived from the monomer, and light emitting device using the polymer |
| 09/06/2006 | CN1829508A Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 09/06/2006 | CN1827616A Synthesis and uses of indole analogs of 1-benzyl-3-(5'-hydroxymethy 1-2' -furyl) indazole |
| 09/06/2006 | CN1273450C 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 09/06/2006 | CN1273444C Dipeptide nitriles |
| 09/06/2006 | CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 09/05/2006 | USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent |
| 09/05/2006 | US7102007 Dihydroindole and tetrahydroquinoline derivatives |
| 09/05/2006 | US7101903 9-(4-Methylbenzyl)-6-[4-(trifluoromethoxy)phenyl]-1,9-dihydropyrano[3,4-b]indole-3,4-dione; treating fibrinolytic disorders, vein thrombosis and coronary heart disease, and pulmonary fibrosis |
| 09/05/2006 | US7101896 Pharmaceutical compositions and methods for use |
| 09/05/2006 | US7101892 2-(4-benzenesulfonyl-4-methyl-pentyl)-5-phenyl-2-aza-bicyclo[2.2.1]heptane; useful for treating sleep disorder, depression, anxiety |
| 09/05/2006 | US7101875 E.g., 4-(2-(1-Benzhydryl-2-(2-((benzylsulfonyl)amino)ethyl)-5-chloro-1H-indol-3 -yl)ethoxy)benzoic acid; inhibitors of phospholipase enzymes, esp. phospholipase A2; antiarthritic and -inflammatory agents; analgesics; rheumatoid diseases |
| 09/05/2006 | US7101867 Benzofuran derivatives, their production and use |
| 09/05/2006 | US7101533 Agent for inducing receptor potential |
| 09/05/2006 | CA2393640C Pyrrolo[2,3-d]pyrimidine compounds |
| 08/31/2006 | WO2006091972A2 Dimeric iap inhibitors |
| 08/31/2006 | WO2006091963A1 Tetrahydroindolone and tetrahydroindazolone derivatives |
| 08/31/2006 | WO2006091646A2 Small molecule inhibitors of mdm2 and uses thereof |
| 08/31/2006 | WO2006090932A1 Surrogate marker for sulfonamide compound |
| 08/31/2006 | WO2006090928A1 Novel use of sulfonamide compound in combination with angiogenesis inhibitor |